Tags
Language
Tags
April 2024
Su Mo Tu We Th Fr Sa
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4

"Ovarian Cancer: Clinical and Therapeutic Perspectives " ed. by Samir Farghaly

Posted By: exLib
"Ovarian Cancer: Clinical and Therapeutic Perspectives " ed. by Samir Farghaly

"Ovarian Cancer: Clinical and Therapeutic Perspectives " ed. by Samir Farghaly
ITAe | 2012 | ISBN: 9789533078106 | 348 pages | PDF | 28 MB

This book provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A comprehensive spectrum of topics is covered providing up to date information on scientific discoveries and management considerations.

International leaders in the field address the critical biologic and basic science issues relevant to the disease. The book details the molecular biological aspects of ovarian cancer. It provides molecular biology techniques of understanding this cancer. The techniques are designed to determine tumor genetics, expression, and protein function, and to elucidate the genetic mechanisms by which gene and immunotherapies may be perfected.

Contents
1 Ovarian Cancer Incidence: Current and Comprehensive Statistics
2 Preventive Strategies in Epithelial Ovarian Cancer
3 Screening for Ovarian Cancer in Women
4 Borderline and Malignant Surface Epithelial - Stromal Tumors of the Ovary
5 Central Nervous System Involvement from Epithelial Ovarian Cancer
6 Peripheral Neuropathy in Ovarian Cancer
7 Therapeutic Strategies in Ovarian Cancer
8 Combined Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for the Treatment of Advanced Ovarian Cancer
9 Minimally Invasive Surgical Procedures for Patients with Advanced and Recurrent Ovarian Cancer
10 Management of Recurrent or Persistent Ovarian Cancer
11 Antiprogestins in Ovarian Cancer
12 Intraperitoneal Radionuclide Therapy - Clinical and Pre-Clinical Considerations
13 Vitamin K2 as a Chemotherapeutic Agent for Treating Ovarian Cancer
14 Second-Line Chemotherapy for Platinum- and Taxane-Resistant Epithelial Ovarian Cancer: Pegylated Liposomal Doxorubicin (PLD), Irinotecan, and Combination Therapies at Lower Doses
15 HER2 as a Therapeutic Target in Ovarian Cancer
16 Sexuality After Ovarian Cancer Therapy
17 Quality of Life of Patients with Ovarian Cancer

with TOC BookMarkLinks
NFlare